AFC
RDY icon

Ares Financial Consulting’s Dr. Reddy's Laboratories RDY Stock Holding History

Ares Financial Consulting’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.59K Hold
110
– – ﹤0.01% 940
2026
Q1 		$1.48K Hold
110
– – ﹤0.01% 896
2025
Q4 		$1.54K Buy
+110
New +$1.54K ﹤0.01% 704

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State of New Jersey Common Pension Fund D
State of New Jersey Common Pension Fund D Trenton, New Jersey $29.3B AUM 38.15% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
AIM
ARGA Investment Management Stamford, Connecticut $3.92B AUM 35.93% 1-Year Est. Return
SFA
Sequoia Financial Advisors Akron, Ohio $20.1B AUM 24.77% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
EI
Ethic Inc New York $8.02B AUM 45.39% 1-Year Est. Return

Ares Financial Consulting's RDY Position: Q2 2026 in Review

Ares Financial Consulting held its Dr. Reddy's Laboratories (RDY) position steady in Q2 2026 at 110 shares worth $1.59K. The position accounts for ﹤0.01% of the portfolio, ranked #940.

Ares Financial Consulting first reported a position in RDY in Q4 2025 and has held it in 3 quarters since. 88 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Ares Financial Consulting held 110 shares of Dr. Reddy's Laboratories worth $1.59K as of Q2 2026.
  • Ares Financial Consulting left its Dr. Reddy's Laboratories share count unchanged in Q2 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Ares Financial Consulting's portfolio in Q2 2026, its #940 holding.
  • Ares Financial Consulting first reported a position in Dr. Reddy's Laboratories in Q4 2025 and has held it in 3 quarters since.
  • 88 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Ares Financial Consulting's 13F filing for Q2 2026, filed 9 Jul 2026.